StockNews.com assumed coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also recently commented on SYRS. JMP Securities dropped their target price on Syros Pharmaceuticals from $16.00 to $15.00 in a […]
StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a research report report published on Thursday. The firm issued a hold rating on the stock. Several other research firms have also weighed in on SYRS. JMP Securities reduced their price objective on shares of Syros Pharmaceuticals from $16.00 to $15.00 in […]
StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the stock. A number of other equities analysts have also recently weighed in on the stock. JMP Securities reduced their price target on shares of Syros Pharmaceuticals from $16.00 to […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokerages that […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 649,500 shares, an increase of 21.6% from the February 28th total of 534,300 shares. Based on an average trading volume of 131,800 shares, the days-to-cover ratio is […]